Search - tctmd.com

Displaying 481 - 500 of 769

Sort: Relevancy | Date

Presentation TCT 2017

Should Pre-Diabetes Affect Revascularization Decisions?

Presenter: David J. Maron, Alan C. Yeung, Clemens von Birgelen

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Presenter: David J. Maron, Alan C. Yeung, Michael E. Farkouh

November 01, 2017

Presentation TCT 2017

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung

November 01, 2017

Presentation TCT 2017

Is There a Preferred Stent for the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Upendra Kaul

November 01, 2017

Presentation TCT 2017

When Should PCI Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Sripal Bangalore

November 01, 2017

Presentation TCT 2017

When Should CABG Be Preferred in the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Jack Boyd

November 01, 2017

Presentation TCT 2017

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

Presenter: John A. Ambrose, Y. S. Chandrashekhar, James E. Muller

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

Presentation TCT 2017

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

Presenter: Hiren Mistry, Michael A. Weber

October 31, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

Renal Denervation Trial Design Considerations: Challenges and Lessons Learned

Presenter: Hiren Mistry, Michael A. Weber, Michael Böhm

October 31, 2017

Presentation TCT 2017

TAP vs Culotte Stenting Beyond The Clinical Trials: A Different View

Presenter: Cihangir Kaymaz, Jeroen Vos, Armando Perez de Prado

October 31, 2017

Presentation TCT 2017

Representation of Women and Minorities in European Trials

Presenter: David P. Faxon, Cindy L. Grines, Angeles Alonso Garcia

October 31, 2017

Presentation TCT 2017

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

Presenter: David P. Faxon, Cindy L. Grines, Roxana Mehran

October 31, 2017

Presentation TCT 2017

FDA Perspectives on Diversity in Clinical Trials

Presenter: David P. Faxon, Cindy L. Grines, Christopher J Popma

October 31, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

Intelligence for Better Clinical Care (Imperative)

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Gopal Chopra

October 31, 2017

News Opinion Off Script TCT 2017

Off Script: Monkey See, Monkey . . . Should Really Do, Before Being Set Loose

Kwan S. Lee

October 30, 2017

Presentation TCT 2017

Pacemaker Mediated Hypertension Treatment (BackBeat): First-in-Man Results and Ongoing Plans

Presenter: Elazer R. Edelman, Paul A. Sobotka, Karl-Heinz Kuck

October 30, 2017

Advertisement

Should Pre-Diabetes Affect Revascularization Decisions?

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

When Is Medical Therapy the Best Choice in the Diabetic Patient?

Is There a Preferred Stent for the Diabetic Patient?

When Should PCI Be Preferred in the Diabetic Patient?

When Should CABG Be Preferred in the Diabetic Patient?

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

Live From Denver: TCT 2017, Day Three

Off Script: Focusing on the Future

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Renal Denervation Trial Design Considerations: Challenges and Lessons Learned

TAP vs Culotte Stenting Beyond The Clinical Trials: A Different View

Representation of Women and Minorities in European Trials

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

FDA Perspectives on Diversity in Clinical Trials

Long-term Absorb BVS Data Continue to Disappoint

Intelligence for Better Clinical Care (Imperative)

Off Script: Monkey See, Monkey . . . Should Really Do, Before Being Set Loose

Pacemaker Mediated Hypertension Treatment (BackBeat): First-in-Man Results and Ongoing Plans

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content